Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L

Slides:

Advertisements

Similar presentations

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.

Advertisements

Toward Magnetic Resonance–Only Simulation: Segmentation of Bone in MR for Radiation Therapy Verification of the Head Huan Yu, PhD, Curtis Caldwell, PhD,

Management of independent motion between multiple targets in lung cancer radiation therapy Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Palliative radiation therapy for superior vena cava syndrome in metastatic Wilms tumor using 10XFFF and 3D surface imaging to avoid anesthesia in a pediatric.

Impact of moving target on measurement accuracy in 3D and 4D PET imaging—a phantom study Yunfeng Cui, PhD, James Bowsher, PhD, Jing Cai, PhD, Fang-Fang.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer Nathan Tennyson, MD, Elisabeth Weiss,

Vaginal Motion and Bladder and Rectal Volumes During Pelvic Intensity-Modulated Radiation Therapy After Hysterectomy Anuja Jhingran, M.D., Mohammad Salehpour,

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD

Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer Shervin M. Shirvani, MD, Ann.

Should we irradiate a brain tumor in a patient with parkinsonism

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology.

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,

Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy Daniel.

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization

Dawn Owen, MD, PhD, Nadia N. Laack, MD, MSc, Charles S

Gastric perforation following stereotactic body radiation therapy of hepatic metastasis from colon cancer Matthew J. Furman, MD, Giles F. Whalen, MD,

Postoperative Proton Therapy in the Management of Stage III Thymoma

Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary Lawrence B. Marks, MD, Robert.

Brenda G. Clark, PhD, Robert J

Effect of bra use during radiation therapy for large-breasted women: Acute toxicity and treated heart and lung volumes Lanea M.M. Keller, MD, MS, Randi.

Required target margins for image-guided lung SBRT: Assessment of target position intrafraction and correction residuals Chirag Shah, MD, Larry L. Kestin,

Jonathan A. Abelson, MD, James D. Murphy, MD, MS, Ellen A

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree Justin M. Haseltine, BSE,

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

My Path from Hiroshima to Houston

Dosimetric Benefits and Practical Pitfalls of Daily Online Adaptive MRI-Guided Stereotactic Radiation Therapy for Pancreatic Cancer Nancy El-Bared, MD,

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Should we irradiate a brain tumor in a patient with parkinsonism

Central3D: A Computer Tool to Help Clinicians Differentiate Central and Peripheral Lung Tumors Dominique Mathieu, MD MSc, Vincent Cousineau Daoust, MSc,

Use of standardized uptake value thresholding for target volume delineation in pediatric Hodgkin lymphoma Amanda J. Walker, MD, Alin Chirindel, MD, Robert.

Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Satomi Shiraishi, PhD, Luis E. Fong de.

Eliminating Daily Shifts, Tattoos, and Skin Marks: Streamlining Isocenter Localization With Treatment Plan Embedded Couch Values for External Beam Radiation.

Tracheoesophageal Fistula Associated with Bevacizumab 21 Months after Completion of Radiation Therapy Elizabeth Gore, MD, Adam Currey, MD, Nicholas Choong,

Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients Mary P. Walker, DDS, PhD, Brian Wichman, MS, An-Lin Cheng, PhD, James.

Action Levels on Dose and Anatomic Variation for Adaptive Radiation Therapy Using Daily Offline Plan Evaluation: Preliminary Results Baoshe Zhang, PhD,

Common error pathways seen in the RO-ILS data that demonstrate opportunities for improving treatment safety Gary Ezzell, PhD, Bhisham Chera, MD, Adam.

Orbital radiation therapy for Graves’ ophthalmopathy: Measuring clinical efficacy and impact Ezra Hahn, MD, Normand Laperriere, MD, FRCPC, Barbara-Ann.

American Society for Radiation Oncology's Performance Assessment for the Advancement of Radiation Oncology Treatment: A practical approach for informing.

Technical Innovations and Patient Support in Radiation Oncology

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Intramedullary Reactive Fibrosis as Mimic of Prostate Cancer Bone Metastasis on 11C- Choline Positron Emission and Computed Tomography Tyler Trump, BS,

Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer Nina Boje.

Vertebral Collapse Caused by Bone Metastasis

Kiran Devisetty, MD, Joseph K. Salama, MD Journal of Thoracic Oncology

Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning.

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Cone-Beam CT-based position verification for oesophageal cancer: Evaluation of registration methods and anatomical changes during radiotherapy A. van.

Effect of Daily and Every Other Day Stereotactic Body Radiation Therapy Schedules on Treatment-Related Fatigue in Patients With Hepatocellular Carcinoma

An Editorial Note: The Long Arm of Practical Radiation Oncology

Ronald C. Chen, MD, MPH, Karen E. Hoffman, MD, David J

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Safety considerations for IMRT: Executive summary

Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,

Phase II Multicenter Trial with Carboplatin and Gemcitabine Induction Chemotherapy Followed by Radiotherapy Concomitantly with Low-Dose Paclitaxel and.

Definition of medical event is to be based on the total source strength for evaluation of permanent prostate brachytherapy: A report from the American.

The posterior cerebellum, a new organ at risk?

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer.

Stereotactic Body Radiation Therapy for the Treatment of Primary Cardiac Angiosarcoma Causing Hemodynamic Instability Prashant Gabani, MD, Benjamin W.

Radiation recall precipitated by iodinated nonionic contrast

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases in Prospective Nonrandomized Studies: A Systematic Review Tetsuo Saito,

Using Smaller-Than-Standard Radiation Treatment Margins Does Not Change Survival Outcomes in Patients with High-Grade Gliomas Kripa Guram, BS, Mark Smith,

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E

Proposed definition of the vaginal cuff and paracolpium clinical target volume in postoperative uterine cervical cancer Naoya Murakami, MD, PhD, Yoshiki.

Presentation transcript:

Anisotropic Bladder Planning Target Volume in Bladder Radiation Therapy Khaled Adil, MD, Marija Popovic, PhD, Fabio L. Cury, MD, Sergio L. Faria, MD, PhD, Marie Duclos, MD, Luis Souhami, MD, FASTRO Practical Radiation Oncology Volume 9, Issue 1, Pages 24-28 (January 2019) DOI: 10.1016/j.prro.2018.07.006 Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

Figure 1 Sagittal (A) and axial (B) views of a planning computed tomography (CT). Magenta contour represents the bladder volume outlined on the planning CT; yellow contours represent bladder volumes on the basis of daily cone beam CT; red contour represents planning target volume PTV 1.5 cm; light blue contour PTV1 cm, and dark blue contour PTV1/1.5 cm. Practical Radiation Oncology 2019 9, 24-28DOI: (10.1016/j.prro.2018.07.006) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions

Figure 2 Sagittal view of patients 3 (A), 8 (B), and 10 (C) showing the bladder expansion predominantly in the anterior and superior directions Practical Radiation Oncology 2019 9, 24-28DOI: (10.1016/j.prro.2018.07.006) Copyright © 2018 American Society for Radiation Oncology Terms and Conditions